The company had clocked a revenue of close to Rs 4,000 crore during FY#39;22. Read More Top 100 Best Sellers Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Name * Email * Website Comment * Save my name, email, and website in this browser for the next time I comment. Δ previousBajaj Healthcare successfully completes USFDA pre-approval inspection of Vadodara plantnextStrides Pharma arms gets USFDA approval for potassium-deficiency drug